大正医疗 (430496.OC)

+ 收藏

现金流量表(大正医疗)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 45,625,824.70107,493,102.1749,269,259.17110,392,583.9750,394,261.81
 收到其他与经营活动有关的现金(元) 201,421.29484,559.61332,174.79944,120.83555,994.13
 经营活动现金流入小计(元) 45,827,245.99107,977,661.7849,601,433.96111,336,704.8050,950,255.94
 购买商品、接受劳务支付的现金(元) 7,230,195.7916,395,551.837,550,285.0915,673,120.368,242,303.23
 支付给职工以及为职工支付的现金(元) 16,072,056.9027,237,100.3915,515,531.7629,412,736.8517,101,926.38
 支付的各项税费(元) 7,796,066.5621,617,379.7213,298,577.7111,952,233.405,236,125.37
 支付其他与经营活动有关的现金(元) 7,217,380.1915,176,280.387,125,419.9414,777,907.666,999,539.90
 经营活动现金流出小计(元) 38,315,699.4480,426,312.3243,489,814.5071,815,998.2737,579,894.88
 经营活动产生的现金流量净额(元) 7,511,546.5527,551,349.466,111,619.4639,520,706.5313,370,361.06
二、投资活动产生的现金流量
 收回投资收到的现金(元) 118,000,000.00175,000,000.00110,000,000.00110,000,000.0043,000,000.00
 取得投资收益收到的现金(元) 575,607.951,185,410.98809,710.96862,383.55312,498.62
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 719,431.00430,453.0015,005.002,077,100.00915,000.00
 处置子公司及其他营业单位收到的现金净额(元) ---1,499,149.62-
 投资活动现金流入小计(元) 119,295,038.95176,615,863.98110,824,715.96114,438,633.1744,227,498.62
 购建固定资产、无形资产和其他长期资产支付的现金(元) 1,381,416.742,549,853.851,137,174.858,237,860.902,552,861.44
 投资支付的现金(元) 123,000,000.00160,000,000.0085,000,000.00153,600,000.0051,000,000.00
 投资活动现金流出小计(元) 124,381,416.74162,549,853.8586,137,174.85161,837,860.9053,552,861.44
 投资活动产生的现金流量净额(元) -5,086,377.7914,066,010.1324,687,541.11-47,399,227.73-9,325,362.82
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) -91,560.0091,560.00--
 筹资活动现金流入小计(元) -91,560.0091,560.00--
 分配股利、利润或偿付利息支付的现金(元) 19,646,000.0039,250,000.0039,250,000.0019,625,000.0019,625,000.00
 筹资活动现金流出小计(元) 19,646,000.0039,250,000.0039,250,000.0019,625,000.0019,625,000.00
 筹资活动产生的现金流量净额(元) -19,646,000.00-39,158,440.00-39,158,440.00-19,625,000.00-19,625,000.00
四、汇率变动对现金及现金等价物的影响(元) 9,381.868,884.0513,495.643,228.187,879.03
五、现金及现金等价物净增加额(元) -17,211,449.382,467,803.64-8,345,783.79-27,500,293.02-15,572,122.73
 加:期初现金及现金等价物余额(元) 29,560,182.1127,092,378.4727,092,378.4754,592,671.4954,592,671.49
 期末现金及现金等价物余额(元) 12,348,732.7329,560,182.1118,746,594.6827,092,378.4739,020,548.76
补充资料:
 净利润(元) 10,602,654.9021,899,032.0712,070,835.4727,259,884.9414,375,771.37
 固定资产和投资性房地产折旧(元) 4,376,669.428,871,513.074,481,602.468,421,307.154,194,141.06
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 4,376,669.428,871,513.074,481,602.468,421,307.154,194,141.06
 无形资产摊销(元) 158,599.26369,905.88184,952.94402,448.03204,152.98
 处置固定资产、无形资产和其他长期资产的损失(元) -26,676.17-97,188.07-158.09-715,763.39-394,253.58
 财务费用(元) -9,381.86-8,884.05-13,495.64-3,228.18-7,879.03
 投资损失(元) -295,051.21-373,244.34-427,110.28292,657.47-294,810.01
 递延所得税(元) -7,765.36-78,638.02-34,389.03-444,198.14-508,709.16
  其中:递延所得税资产减少(元) -7,765.3669,665.02-34,389.03-1,097,832.68-508,709.16
 递延所得税负债增加(元) --148,303.04-653,634.54-
 存货的减少(元) 924,803.83-1,573,157.01-2,088,587.11-297,921.8389,253.21
 经营性应收项目的减少(元) 1,335,396.052,639,377.373,022,524.633,098,055.99365,613.43
 经营性应付项目的增加(元) -9,389,251.36-4,579,344.21-11,312,603.23614,724.09-5,009,158.00
 现金的期末余额(元) 12,348,732.7329,560,182.1118,746,594.6827,092,378.4739,020,548.76
 减:现金的期初余额(元) 29,560,182.1127,092,378.4727,092,378.4754,592,671.4954,592,671.49
 现金及现金等价物的净增加额(元) -17,211,449.382,467,803.64-8,345,783.79-27,500,293.02-15,572,122.73
公告日期 2024-08-272024-04-252023-08-242023-04-212022-08-23
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院